Dr. Ami Klin


Photo courtesy of Tribune News Service

PREVENTION. Dr. Ami Klin has done considerable research with detecting autism markers among infants. He aims to lower the age of detection and improve access to early treatment. The goal is to improve outcomes for children with autism.

Dr. Ami Klin is the first director of the Marcus Autism Center at Children’s Healthcare of Atlanta and Emory University School of Medicine.

This is the largest center of clinical care for children with autism and their families as well as one of only three National Institute of Health (NIH) Autism Centers of Excellence.

Klin is also the Georgia Research Alliance Eminent Scholar Professor.

The internationally recognized clinical psychologist and researcher obtained his PhD from the University of London and completed fellowships at the Yale Child Study Center, eventually directing its autism program as the Harris Professor of Child Psychology and Psychiatry until 2010.

Klin’s primary research activities focus on the social mind and brain, honing in on aspects of autism from infancy through adulthood.

These included new techniques such as eye-tracking technology, developed in collaboration with Dr. Warren Jones, which is used to visualize and measure social engagement, allowing researchers to see the world through the eyes of autistic individuals.

A recent area of focus involves closely monitoring infants with an increased risk for developmental disabilities from birth. The goal is to detect markers for autism early on as well as improve access to early treatment.

Klin has published numerous books regarding his research on autism.